Recursion Pharmaceuticals RXRX Stock News and Forecasts on December 21 2025
Recursion Pharmaceuticals, Inc. stock (NASDAQ: RXRX) heads into the week of December 21, 2025 with investors focused on one thing above all: whether newly released clinical data can turn Recursion’s long-running “AI drug discovery” promise into a credible, repeatable pipeline story that ultimately becomes commercial revenue. The near-term backdrop is noisy. RXRX has been highly volatile for years, and even now the share price sits far below its prior highs, a reality that shapes how every catalyst is interpreted. The Motley Fool Below is a roundup of the key RXRX stock news, fresh filings, analyst forecasts, and the most cited